SlideShare a Scribd company logo
Diabetic neuropathy
DR A.DINESH
1ST YEAR PG, GEN MED
 PREVALENCE:
~50% (18.8 – 61.9%) of indiviuals with long
standing T1DM , T2DM develops diabetic
neuropathy.
Diabetic Neuropathy accounts a major
contributor of all neuropathies (~27%)
OTHERS
HIV/AIDS
CHEMO
RISK FACTORS:
Duration of diabetes
Advancing age
OTHER RISK FACTORS:
Smoking
Hypertension
Dyslipidemia
malnourishment
Pathogenesis
 Increased aldose reductase activity
 Nerve ischemia /hypoxia
 Auto oxidation of glucose
 Non Enzymatic Glycation End products (AGE)
 Activation of protein kinase C
 Oxidative stress
 Reduced serum levels of nerve growth factors
Aldose reductase overactivity
Nerve ischemia/hypoxia
classification
 SYMMETRIC / ASYMMETRIC NEUROPATHY
 AUTONOMIC NEUROPATHY
 MONONEUROPATHY AND ENTRAPMENT
SYNDROME
 RADICULOPATHY/ POLYRADICULOPATHY
 SUPER IMPOSED CIDP
 TREATMENT INDUCED DIABETIC NEUROPATHY
SYMMETRIC NEUROPATHY:
SENSORY/SENSORIMOTOR/MOTOR
DSPN – DISTAL SYMMETRIC POLYNEUROPATHY
SMALL FIBER
NEUROPATHY
LARGE
FIBER
NEUROPATH
Y
MIXED SMALL
AND LARGE
FIBER
NEUROPATHY
MOST COMMON
DSPN
 Most common form of diabetic neuropathy
 A mixed neuropathy with small, large fiber,
autonomic, motor involvement( late stage).
 In a patient with DM if there are clinical signs of
autonomic abnormalities , DSPN is invariably
present.
 Insidious, progressive
 DSPN as “the presence of symptoms and signs of
peripheral nerve dysfunction in people with diabetes
after exclusion of other causes”
Symptoms:
 As small fibers are predominantly involved
early the symptoms are related to damage of
small fibers.
 Pain- dull constant pain/ sharp shooting or
stabbing pain
 Hyperalgesia
 Allodynia
 Loss of thermal sensation
 Loss of pain(later stages)
these symptoms are the main
presentation in prediabetic individuals.
 Symptoms worsens at night
 Manifested in the feet more than the hands
 Paresthesia or episodes of distorted sensation such as pins
and needles,
 tingling,
 coldness,
 numbness-feeling like walking in cotton,
 burning sensation -hot foot.
 often accompany the pain.
as a whole these are called“POSITIVE SYMPTOMS”
DSPN WITH LARGE FIBER NEUROPATHY – presents with
insensate foot,
Poor balancing,
Distal weakness of toes& ankles in later stages are called
”NEAGATIVE SYMPTOMS”
SIGNS:
Sensory:
loss or imapairment of sensation of toes
and feet. Vibration sense often the first to go.
as the sensory loss extends proximally
from a sock to stocking distribution the finger tips
become involved
Autonomic:
dry skin , fissures, callouses
Motor:
absent ankle reflex (large fibers), wasting
of toe muscles
AUTONOMIC NEUROPATHY
CARDIAC AUTONOMIC
NEUROPATHY
SIGNS/SYMPTOMS MECHANISM
RESTING TACHYCARDIA VAGAL IMPAIRMENT & (sympathetic
takeover)
REDUCED HRV EARLY FINDING
REDUCED RESPONSE TO HR, BP IN
EXERCISE, STRESS, SLEEP
ORTHOSTATIC
HYPOTENSION
DAMAGE TO EFFERENT SYMPATHETIC
VASOMOTOR FIBERS
SYMPTOMS:
Lightheadedness, dizziness, weakness,
fatigue, neck pain, blurring of vision
SILENT MI ALTERED PAIN THRESHOLD/
SUBTHRESHOLD ISCHEMIS NOT
SUFFICIENT TO INDUCE PAIN,
DYSFUNCTION OF AFFRENT AUTONOMIC
FIBERS
CARDIOMYOPATHY LEFT VENTRICLE DIASTOLIC
DYSFUNCTION, LOW PEAK DIASTOLIC
GI DIABETIC NEUROPATHY
MECHANISM SIGNS/SYMPTOMS
GASTROPARESIS
DELAYED GASTRIC EMPTYING
( DUE TO HYPERGLYCEMIA OR
HYPERGLYCEMIA INDUCED
PARASYMPTHETIC
DYSFUNCTION)
BLOATING SENSATION
EARLY SATIETY
INDIGESTION
NAUSEA, HEARTBURN
ENTEROPATHY DIARRHEA ( NOCTURNAL
DIARRHOEA)
FECAL INCONTINENCE
MAY ALTERNATE WITH
CONSTIPATION
COLONIC HYPOMOTILITY CONSTIPATION
UROGENITAL D.NEUROPATHY
BLADDER DYSFUNCTION
(INABILITY TO SENSE FULL
BLADDER,
FAILURE TO VOID
COMPLETELY)
INCREASED FREQUENCY
URGENCY, NOCTURIA,
WEAK STREAM, DRIBBLING,
INCONTINENCE,
URINARY RETENTION
MALE SEXUAL
DYSFUNCTION
ERECTILE DYSFUNCTION
DECREASED LIBIDO
PREMATURE EJACULATION,
RETROGRADE EJACULATION
FEMALE SEXUAL
DYSFUNCTION
DECREASED SEXUAL DESIRE,
DYSPAREUNIA
INADEQUATE LUBRICATION
DECREASED SEXUAL AROUSAL
SUDOMOTOR ANHIDROSIS
GUSTATORY SWEATING
OTHER AUTONOMIC
NEUROPATHIC SYMPTOMS:
 ABNORMAL PUPILLARY FUNCTION-
SMALL UNREACTIVE PUPIL
 HYPOGLYCMEIC UNAWARENESS
 SLEEP APNEA
MONO NEUROAPTHY
 CRANIAL NERVE INVOLVEMENT:
 Nerves of extra occular muscles are commonly
affected.
 Occulomotor nerve palsy III: ( 42% microvascular causes)
# Abrupt onset,
# retro orbital pain,
# ptosis,
# ophthalmoplegia with
sparing of pupilary fuction
Muscles supplied by 3rd nr: SR, IR, MR, IO
Other cranial nerves affected: 6, 7, 4(less common)
III NR PALSY:
MONO NEUROAPTHY
 Peripheral nerves – ulnar, median, radial, lateral
popliteal nerve.
 Entrappment neuropathies are common.
 Carpel tunnel syndrome- median Nr
 Pathogenesis: swelling of synovial sheaths around
carpal tunnel due to fluid accumulation, inflammation,
injury, external compression increases intra tunnel
pressure which damages myelin sheath,impairs
axonal flow & blocks micro circulation of median nerve
causes pain , tingling, numbness sensation
 Cubital tunnel syndrome- ulnar nerve at elbow
 common peroneal Nr: at head of fibula
Radiculopathy
 TRUNCAL RADICULOPATHY:
Abrupt onset of pain pain over
area of chest and abdomen which worsens at
night.
thoracic lumbar spinal nerve roots
are commonly involved
focal anterior abdominal wall
weakness- pseudohernia
Lumbo sacral
Radiculoplexopathy
OTHER NAME: “BRUNS GARLAND SYNDROME”
Diabetic amyotrophy, proximal motor neuropathy
 Male>female in T2 DM
 Pathogenesis : micro vasculitis leads to ischemeic nerve
injury
 Severe pain in unilateral/bilateral thighs, lowerback
 Followed by lowerlimb muscle weakness often proximal &
unilateral
 Knee jerk reduced or absent
SUPERIMPOSED CIDP
 A chronic condition >8 weeks
 A type of secondary CDIP
 Chronic hyperglycemic state impairs neuronal
microcirculation leads to myelin damage. As a chronic
insult spinal nerve roots release chemokines into CSF
leads to increse TNF, IL production activates CD4
cells which targets myelin sheaths and destroys leads
to nerve damage.
 Symptoms: presents with proximal muscle weakness
and sensory involvement
HYPOGLYCEMIC
NEUROPATHY
 It is treatment induced neuropathy where it
probably due to microcirculation deficit in
hyperglycemic period. As soon as the blood sugar
levels was corrected microcirculation was not not
restored as early because of endoneurial
ischemia and the formation of axonal regeneration
zonesupon attaining normoglycemic state
producing ectopic depolarisations and pain starts
2-6 weeks after improvement of glycemic control
INVESTIGATIONS
 Blood glucose/ HbA1c
 Urine analysis for protein/glucose
 RFT/Electrolytes
 Vitamin B12 levels
 Serum protein
 Lipid profile
 CT/MRI brain (cranial nr palsy)
 CT Pelvis (motor neuropathy)
 NC study
 EMG study
Nerve conduction study
 It is a measure of how fast the nerve conduct the
impulses
 Used in cases of paresthesia, weakness of arms or legs
 Procedure:
 1.electrodes will be taped to skin along the nerves that
are being studied
2.Small stimulus is applied(electric current) that activate
nerves
3.The electode will measure the current the current that
travells down the nerve pathway
If damaged? – the current will be slower/weaker
Time of procedure- 30-90 min
Complications- little discomfort from electric current, not painful
Advantage:
- non invasive, no anaesthesia needed
- detect asymptomatic cases
- monitering of progression/ remission of disease
 INTERPRETATION:
 Speed of conduction depends on diameter of nerve
and degree of myelination.
 In general , the range of normal conduction velocity will
be approx 50-60 m/sec, however it vary from one nervr
to another and and also individual variablility.
 Eg:
Slow NCS Indicates damage to myelin
Slowing across wrist jt for motor
&sensory latancies of median nerve
Indiacates compression of median nr
– carpal tunnel synd
Slowing of all nr conduction in
>1limb
Indicates polyneuropathy
Treatment
CORRECTION OF UNDERLYING PATHOGENEIC
MECHANISM:
 NORMALISATION OF BLOOD GLUCOSE
 ANTIOXIDANT THERAPHY
 ALDOSE REDUCTASE INHIBITOR
 GROWTH FACTOR ANALOGUE
PHYSICAL APPROACH PHARMACOLOGICAL APPROACH
PROPER FOOT WEAR NSAIDS
FOOT CARE ANTI DEPRESSANTS
PHYSIOTHERAPHY ANTICONVULSANTS
NOCTURNAL SPLINT ANTIOXIDANTS, AGE INHIBITORS
Anti convulsants:
 GABA ANALOGUES: Gabapentin, pregabalin
(-) Ady cyclase, +k+ channels, (-)ca2+influx
pregabalin Gabapentin
Initial dose 25-75mg 1-3*/day 100-300mg 1-3*/day
Effective dose 300-600mg/day 900- 3,600mg/day
Common Adverse
effects
Somnolence
Dizziness
Headache
Ataxia
Fatigue
Weight gain
xerostomia
Somnolence
Dizziness
Headache
Ataxia
Fatigue
Major adverse effects Hepatotoxic
Angioedema
Rhabdomyolysis
Thrombocytopenia
Suicidal thoughts
Steven johnson
syndrome
Suicidal thoughts
Seizure after
discontinuation
Anti depressants: SNRI
duloxetine venlafaxine
Initial dose 20-30 mg/ day 37.5 mg/day
Maximum dose 60-120 mg/day 75-225 mg/day
Common adverse
effects
Dizziness, insomnia,
somnolence, anorexia,
fatigue, decreased
libido
same
Major adverse effects SJS,
HT crisis,
GI bleed,
Delirium,
MI, arrythmia,
heapatotoxic,
glaucoma, seizure,
hyponatremia
Neuroleptic malignant
syndrome
same
Tricyclic anti-depressants
Amitryptalline Nortyrptalline Desipramine
Initial dose 10-25 mg/day
Max dose 25-100 mg/day
Adverse effects Dizziness,
insomnia,
somnolence,
anorexia, fatigue,
xerostommia,
somnolence,
urinary retention, ,
constipation,
blurred vision,
weight gain,
mmydriasis
Major adverse
effects
Same as duloxetine
ALPHA LIPOIC ACID
 Anti oxidant
 600 mg/day iv for 5 -14 days
 Improves neuropathic symptoms including
pain
Aldose reductase inhibitors
 Tolrestat, epalrestat, ranirestat, fidarestat
 Potentially slow or reverse the progression of
neuropathy
 Under clinical trail
Refractory neuropathic pain
 Phenothiazines
 Opioids –Tramadol
 Lidocaine
 Mexiletine
 Local nerve blocks

More Related Content

What's hot

Diabetes Mellitus Type 2
Diabetes Mellitus Type 2Diabetes Mellitus Type 2
Diabetes Mellitus Type 2
AdamBilski2
 
FCPD by Dr Shahjada Seim
FCPD by Dr Shahjada SeimFCPD by Dr Shahjada Seim
LADA & MODY DIABETES
LADA & MODY DIABETESLADA & MODY DIABETES
LADA & MODY DIABETES
Kurian Joseph
 
diabetic ketoacidosis DKA
diabetic ketoacidosis DKAdiabetic ketoacidosis DKA
diabetic ketoacidosis DKA
home
 
Lada and mody
Lada and modyLada and mody
Lada and mody
Sriloy Mohanty
 
Diabetic neuropathy
Diabetic neuropathyDiabetic neuropathy
Diabetic neuropathy
Dr. Tushar Patil
 
Diabetic neuropathy
Diabetic neuropathyDiabetic neuropathy
Diabetic neuropathy
MahimaBharathi
 
Rhabdomyolysis
RhabdomyolysisRhabdomyolysis
Rhabdomyolysis
Irina Bubnova
 
Dyslipidemia [Compatibility Mode]
Dyslipidemia [Compatibility Mode]Dyslipidemia [Compatibility Mode]
Dyslipidemia [Compatibility Mode]
Jimma university
 
Chronic inflammatory demyelinating Polyradiculoneuropathy
Chronic inflammatory demyelinating Polyradiculoneuropathy Chronic inflammatory demyelinating Polyradiculoneuropathy
Chronic inflammatory demyelinating Polyradiculoneuropathy
Ajay Kumar
 
Dyslipidemia
DyslipidemiaDyslipidemia
DIABETIC EMERGENCIES- DKA / HONK / HYPOGLYCEMIA
DIABETIC EMERGENCIES- DKA / HONK / HYPOGLYCEMIADIABETIC EMERGENCIES- DKA / HONK / HYPOGLYCEMIA
DIABETIC EMERGENCIES- DKA / HONK / HYPOGLYCEMIA
Dr. Darayus P. Gazder
 
Diabetic Microvascular Complications
Diabetic  Microvascular  ComplicationsDiabetic  Microvascular  Complications
Diabetic Microvascular Complications
drmathewjohn
 
A Case of CIDP
A Case of CIDPA Case of CIDP
Approach to Chronic Kidney Diseases
Approach to Chronic Kidney DiseasesApproach to Chronic Kidney Diseases
Approach to Chronic Kidney Diseases
Beka Aberra
 
Approach to chronic kidney disease abhijith
Approach to chronic kidney disease abhijithApproach to chronic kidney disease abhijith
Approach to chronic kidney disease abhijith
V Abhijith
 
Diabetes
DiabetesDiabetes
Macrovascular disease in diabetes
Macrovascular disease in diabetesMacrovascular disease in diabetes
Macrovascular disease in diabetes
PeninsulaEndocrine
 
Cidp ajay
Cidp ajayCidp ajay
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
Nasir Nazeer
 

What's hot (20)

Diabetes Mellitus Type 2
Diabetes Mellitus Type 2Diabetes Mellitus Type 2
Diabetes Mellitus Type 2
 
FCPD by Dr Shahjada Seim
FCPD by Dr Shahjada SeimFCPD by Dr Shahjada Seim
FCPD by Dr Shahjada Seim
 
LADA & MODY DIABETES
LADA & MODY DIABETESLADA & MODY DIABETES
LADA & MODY DIABETES
 
diabetic ketoacidosis DKA
diabetic ketoacidosis DKAdiabetic ketoacidosis DKA
diabetic ketoacidosis DKA
 
Lada and mody
Lada and modyLada and mody
Lada and mody
 
Diabetic neuropathy
Diabetic neuropathyDiabetic neuropathy
Diabetic neuropathy
 
Diabetic neuropathy
Diabetic neuropathyDiabetic neuropathy
Diabetic neuropathy
 
Rhabdomyolysis
RhabdomyolysisRhabdomyolysis
Rhabdomyolysis
 
Dyslipidemia [Compatibility Mode]
Dyslipidemia [Compatibility Mode]Dyslipidemia [Compatibility Mode]
Dyslipidemia [Compatibility Mode]
 
Chronic inflammatory demyelinating Polyradiculoneuropathy
Chronic inflammatory demyelinating Polyradiculoneuropathy Chronic inflammatory demyelinating Polyradiculoneuropathy
Chronic inflammatory demyelinating Polyradiculoneuropathy
 
Dyslipidemia
DyslipidemiaDyslipidemia
Dyslipidemia
 
DIABETIC EMERGENCIES- DKA / HONK / HYPOGLYCEMIA
DIABETIC EMERGENCIES- DKA / HONK / HYPOGLYCEMIADIABETIC EMERGENCIES- DKA / HONK / HYPOGLYCEMIA
DIABETIC EMERGENCIES- DKA / HONK / HYPOGLYCEMIA
 
Diabetic Microvascular Complications
Diabetic  Microvascular  ComplicationsDiabetic  Microvascular  Complications
Diabetic Microvascular Complications
 
A Case of CIDP
A Case of CIDPA Case of CIDP
A Case of CIDP
 
Approach to Chronic Kidney Diseases
Approach to Chronic Kidney DiseasesApproach to Chronic Kidney Diseases
Approach to Chronic Kidney Diseases
 
Approach to chronic kidney disease abhijith
Approach to chronic kidney disease abhijithApproach to chronic kidney disease abhijith
Approach to chronic kidney disease abhijith
 
Diabetes
DiabetesDiabetes
Diabetes
 
Macrovascular disease in diabetes
Macrovascular disease in diabetesMacrovascular disease in diabetes
Macrovascular disease in diabetes
 
Cidp ajay
Cidp ajayCidp ajay
Cidp ajay
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 

Similar to Diabetic neuropathy DR DINESH.pptx

Sensory manifestations of systemic diseases
Sensory manifestations of systemic diseasesSensory manifestations of systemic diseases
Sensory manifestations of systemic diseases
Ahmed Abdelraheem
 
PERIPHERAL NEUROPATHY
PERIPHERAL NEUROPATHYPERIPHERAL NEUROPATHY
PERIPHERAL NEUROPATHY
Aaishwaryaa Rai
 
APPROACH TO A PATIENT PRESENTING WITH LIMB WEAKNESS
APPROACH TO A PATIENT PRESENTING WITH LIMB WEAKNESSAPPROACH TO A PATIENT PRESENTING WITH LIMB WEAKNESS
APPROACH TO A PATIENT PRESENTING WITH LIMB WEAKNESS
PituaIvaan1
 
Approach to Peripheral Neuropathy
Approach to Peripheral NeuropathyApproach to Peripheral Neuropathy
Approach to Peripheral Neuropathy
Stanley Medical College, Department of Medicine
 
Approach to peripheral neuropathy
Approach to peripheral neuropathyApproach to peripheral neuropathy
Approach to peripheral neuropathy
NeurologyKota
 
Approach to patient with peripheral neuropathy
Approach to patient with peripheral neuropathyApproach to patient with peripheral neuropathy
Approach to patient with peripheral neuropathy
DrAnusha3
 
Nervous system / neurological involvement in ckd
Nervous system / neurological involvement in ckdNervous system / neurological involvement in ckd
Nervous system / neurological involvement in ckd
Manish Singla
 
Non-Compressive Myelopathy
Non-Compressive MyelopathyNon-Compressive Myelopathy
4. Peripheral-Neuropathy.ppt
4. Peripheral-Neuropathy.ppt4. Peripheral-Neuropathy.ppt
4. Peripheral-Neuropathy.ppt
AbwoneKenneth
 
Cns Neuropathy Davidson07.
Cns Neuropathy  Davidson07.Cns Neuropathy  Davidson07.
Cns Neuropathy Davidson07.
Shaikhani.
 
STROKE INTRODUCTION, CLASSIFICATION AND CLINICAL FEATURES.pptx
STROKE INTRODUCTION, CLASSIFICATION AND CLINICAL FEATURES.pptxSTROKE INTRODUCTION, CLASSIFICATION AND CLINICAL FEATURES.pptx
STROKE INTRODUCTION, CLASSIFICATION AND CLINICAL FEATURES.pptx
DRNEHAINGALECHAUDHAR
 
Chronic limb ischemia
Chronic limb ischemia Chronic limb ischemia
Chronic limb ischemia
Kundan Singh
 
Peripheral neuropathy
Peripheral neuropathyPeripheral neuropathy
Peripheral neuropathy
Sanjay Bhat
 
Peripheral neuropathy
Peripheral neuropathyPeripheral neuropathy
Peripheral neuropathy
sabir khadka
 
Peripheral neuropathy
Peripheral neuropathyPeripheral neuropathy
Peripheral neuropathy
anoop k r
 
Neurological Disorders
Neurological DisordersNeurological Disorders
Neurological Disorders
meducationdotnet
 
Diagnostic methods
Diagnostic methodsDiagnostic methods
Diagnostic methods
Ola
 
Syndromes Of Spinal Cord
Syndromes Of Spinal CordSyndromes Of Spinal Cord
Common Neurological Disorders for undergraduates( MBBS, NURSING,PHRMA STUDENT...
Common Neurological Disorders for undergraduates( MBBS, NURSING,PHRMA STUDENT...Common Neurological Disorders for undergraduates( MBBS, NURSING,PHRMA STUDENT...
Common Neurological Disorders for undergraduates( MBBS, NURSING,PHRMA STUDENT...
Dr Ganeshgouda Majigoudra Consultant Neurologist Nanjappa hospitals
 
NEUROMYOTONIA : A COMPLETE REVIEW
NEUROMYOTONIA : A COMPLETE REVIEWNEUROMYOTONIA : A COMPLETE REVIEW
NEUROMYOTONIA : A COMPLETE REVIEW
Shourya Reddy
 

Similar to Diabetic neuropathy DR DINESH.pptx (20)

Sensory manifestations of systemic diseases
Sensory manifestations of systemic diseasesSensory manifestations of systemic diseases
Sensory manifestations of systemic diseases
 
PERIPHERAL NEUROPATHY
PERIPHERAL NEUROPATHYPERIPHERAL NEUROPATHY
PERIPHERAL NEUROPATHY
 
APPROACH TO A PATIENT PRESENTING WITH LIMB WEAKNESS
APPROACH TO A PATIENT PRESENTING WITH LIMB WEAKNESSAPPROACH TO A PATIENT PRESENTING WITH LIMB WEAKNESS
APPROACH TO A PATIENT PRESENTING WITH LIMB WEAKNESS
 
Approach to Peripheral Neuropathy
Approach to Peripheral NeuropathyApproach to Peripheral Neuropathy
Approach to Peripheral Neuropathy
 
Approach to peripheral neuropathy
Approach to peripheral neuropathyApproach to peripheral neuropathy
Approach to peripheral neuropathy
 
Approach to patient with peripheral neuropathy
Approach to patient with peripheral neuropathyApproach to patient with peripheral neuropathy
Approach to patient with peripheral neuropathy
 
Nervous system / neurological involvement in ckd
Nervous system / neurological involvement in ckdNervous system / neurological involvement in ckd
Nervous system / neurological involvement in ckd
 
Non-Compressive Myelopathy
Non-Compressive MyelopathyNon-Compressive Myelopathy
Non-Compressive Myelopathy
 
4. Peripheral-Neuropathy.ppt
4. Peripheral-Neuropathy.ppt4. Peripheral-Neuropathy.ppt
4. Peripheral-Neuropathy.ppt
 
Cns Neuropathy Davidson07.
Cns Neuropathy  Davidson07.Cns Neuropathy  Davidson07.
Cns Neuropathy Davidson07.
 
STROKE INTRODUCTION, CLASSIFICATION AND CLINICAL FEATURES.pptx
STROKE INTRODUCTION, CLASSIFICATION AND CLINICAL FEATURES.pptxSTROKE INTRODUCTION, CLASSIFICATION AND CLINICAL FEATURES.pptx
STROKE INTRODUCTION, CLASSIFICATION AND CLINICAL FEATURES.pptx
 
Chronic limb ischemia
Chronic limb ischemia Chronic limb ischemia
Chronic limb ischemia
 
Peripheral neuropathy
Peripheral neuropathyPeripheral neuropathy
Peripheral neuropathy
 
Peripheral neuropathy
Peripheral neuropathyPeripheral neuropathy
Peripheral neuropathy
 
Peripheral neuropathy
Peripheral neuropathyPeripheral neuropathy
Peripheral neuropathy
 
Neurological Disorders
Neurological DisordersNeurological Disorders
Neurological Disorders
 
Diagnostic methods
Diagnostic methodsDiagnostic methods
Diagnostic methods
 
Syndromes Of Spinal Cord
Syndromes Of Spinal CordSyndromes Of Spinal Cord
Syndromes Of Spinal Cord
 
Common Neurological Disorders for undergraduates( MBBS, NURSING,PHRMA STUDENT...
Common Neurological Disorders for undergraduates( MBBS, NURSING,PHRMA STUDENT...Common Neurological Disorders for undergraduates( MBBS, NURSING,PHRMA STUDENT...
Common Neurological Disorders for undergraduates( MBBS, NURSING,PHRMA STUDENT...
 
NEUROMYOTONIA : A COMPLETE REVIEW
NEUROMYOTONIA : A COMPLETE REVIEWNEUROMYOTONIA : A COMPLETE REVIEW
NEUROMYOTONIA : A COMPLETE REVIEW
 

Recently uploaded

Pengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptxPengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptx
Fajar Baskoro
 
BIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptx
BIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptxBIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptx
BIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptx
RidwanHassanYusuf
 
Wound healing PPT
Wound healing PPTWound healing PPT
Wound healing PPT
Jyoti Chand
 
Film vocab for eal 3 students: Australia the movie
Film vocab for eal 3 students: Australia the movieFilm vocab for eal 3 students: Australia the movie
Film vocab for eal 3 students: Australia the movie
Nicholas Montgomery
 
Mule event processing models | MuleSoft Mysore Meetup #47
Mule event processing models | MuleSoft Mysore Meetup #47Mule event processing models | MuleSoft Mysore Meetup #47
Mule event processing models | MuleSoft Mysore Meetup #47
MysoreMuleSoftMeetup
 
Gender and Mental Health - Counselling and Family Therapy Applications and In...
Gender and Mental Health - Counselling and Family Therapy Applications and In...Gender and Mental Health - Counselling and Family Therapy Applications and In...
Gender and Mental Health - Counselling and Family Therapy Applications and In...
PsychoTech Services
 
UGC NET Exam Paper 1- Unit 1:Teaching Aptitude
UGC NET Exam Paper 1- Unit 1:Teaching AptitudeUGC NET Exam Paper 1- Unit 1:Teaching Aptitude
UGC NET Exam Paper 1- Unit 1:Teaching Aptitude
S. Raj Kumar
 
How to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 InventoryHow to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 Inventory
Celine George
 
HYPERTENSION - SLIDE SHARE PRESENTATION.
HYPERTENSION - SLIDE SHARE PRESENTATION.HYPERTENSION - SLIDE SHARE PRESENTATION.
HYPERTENSION - SLIDE SHARE PRESENTATION.
deepaannamalai16
 
spot a liar (Haiqa 146).pptx Technical writhing and presentation skills
spot a liar (Haiqa 146).pptx Technical writhing and presentation skillsspot a liar (Haiqa 146).pptx Technical writhing and presentation skills
spot a liar (Haiqa 146).pptx Technical writhing and presentation skills
haiqairshad
 
Temple of Asclepius in Thrace. Excavation results
Temple of Asclepius in Thrace. Excavation resultsTemple of Asclepius in Thrace. Excavation results
Temple of Asclepius in Thrace. Excavation results
Krassimira Luka
 
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
PECB
 
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdfمصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
سمير بسيوني
 
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdfREASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
giancarloi8888
 
Benner "Expanding Pathways to Publishing Careers"
Benner "Expanding Pathways to Publishing Careers"Benner "Expanding Pathways to Publishing Careers"
Benner "Expanding Pathways to Publishing Careers"
National Information Standards Organization (NISO)
 
Lifelines of National Economy chapter for Class 10 STUDY MATERIAL PDF
Lifelines of National Economy chapter for Class 10 STUDY MATERIAL PDFLifelines of National Economy chapter for Class 10 STUDY MATERIAL PDF
Lifelines of National Economy chapter for Class 10 STUDY MATERIAL PDF
Vivekanand Anglo Vedic Academy
 
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptxC1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
mulvey2
 
Nutrition Inc FY 2024, 4 - Hour Training
Nutrition Inc FY 2024, 4 - Hour TrainingNutrition Inc FY 2024, 4 - Hour Training
Nutrition Inc FY 2024, 4 - Hour Training
melliereed
 
Leveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit InnovationLeveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit Innovation
TechSoup
 
A Visual Guide to 1 Samuel | A Tale of Two Hearts
A Visual Guide to 1 Samuel | A Tale of Two HeartsA Visual Guide to 1 Samuel | A Tale of Two Hearts
A Visual Guide to 1 Samuel | A Tale of Two Hearts
Steve Thomason
 

Recently uploaded (20)

Pengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptxPengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptx
 
BIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptx
BIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptxBIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptx
BIOLOGY NATIONAL EXAMINATION COUNCIL (NECO) 2024 PRACTICAL MANUAL.pptx
 
Wound healing PPT
Wound healing PPTWound healing PPT
Wound healing PPT
 
Film vocab for eal 3 students: Australia the movie
Film vocab for eal 3 students: Australia the movieFilm vocab for eal 3 students: Australia the movie
Film vocab for eal 3 students: Australia the movie
 
Mule event processing models | MuleSoft Mysore Meetup #47
Mule event processing models | MuleSoft Mysore Meetup #47Mule event processing models | MuleSoft Mysore Meetup #47
Mule event processing models | MuleSoft Mysore Meetup #47
 
Gender and Mental Health - Counselling and Family Therapy Applications and In...
Gender and Mental Health - Counselling and Family Therapy Applications and In...Gender and Mental Health - Counselling and Family Therapy Applications and In...
Gender and Mental Health - Counselling and Family Therapy Applications and In...
 
UGC NET Exam Paper 1- Unit 1:Teaching Aptitude
UGC NET Exam Paper 1- Unit 1:Teaching AptitudeUGC NET Exam Paper 1- Unit 1:Teaching Aptitude
UGC NET Exam Paper 1- Unit 1:Teaching Aptitude
 
How to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 InventoryHow to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 Inventory
 
HYPERTENSION - SLIDE SHARE PRESENTATION.
HYPERTENSION - SLIDE SHARE PRESENTATION.HYPERTENSION - SLIDE SHARE PRESENTATION.
HYPERTENSION - SLIDE SHARE PRESENTATION.
 
spot a liar (Haiqa 146).pptx Technical writhing and presentation skills
spot a liar (Haiqa 146).pptx Technical writhing and presentation skillsspot a liar (Haiqa 146).pptx Technical writhing and presentation skills
spot a liar (Haiqa 146).pptx Technical writhing and presentation skills
 
Temple of Asclepius in Thrace. Excavation results
Temple of Asclepius in Thrace. Excavation resultsTemple of Asclepius in Thrace. Excavation results
Temple of Asclepius in Thrace. Excavation results
 
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
 
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdfمصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
 
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdfREASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
 
Benner "Expanding Pathways to Publishing Careers"
Benner "Expanding Pathways to Publishing Careers"Benner "Expanding Pathways to Publishing Careers"
Benner "Expanding Pathways to Publishing Careers"
 
Lifelines of National Economy chapter for Class 10 STUDY MATERIAL PDF
Lifelines of National Economy chapter for Class 10 STUDY MATERIAL PDFLifelines of National Economy chapter for Class 10 STUDY MATERIAL PDF
Lifelines of National Economy chapter for Class 10 STUDY MATERIAL PDF
 
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptxC1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
 
Nutrition Inc FY 2024, 4 - Hour Training
Nutrition Inc FY 2024, 4 - Hour TrainingNutrition Inc FY 2024, 4 - Hour Training
Nutrition Inc FY 2024, 4 - Hour Training
 
Leveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit InnovationLeveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit Innovation
 
A Visual Guide to 1 Samuel | A Tale of Two Hearts
A Visual Guide to 1 Samuel | A Tale of Two HeartsA Visual Guide to 1 Samuel | A Tale of Two Hearts
A Visual Guide to 1 Samuel | A Tale of Two Hearts
 

Diabetic neuropathy DR DINESH.pptx

  • 2.  PREVALENCE: ~50% (18.8 – 61.9%) of indiviuals with long standing T1DM , T2DM develops diabetic neuropathy. Diabetic Neuropathy accounts a major contributor of all neuropathies (~27%) OTHERS HIV/AIDS CHEMO
  • 7. Pathogenesis  Increased aldose reductase activity  Nerve ischemia /hypoxia  Auto oxidation of glucose  Non Enzymatic Glycation End products (AGE)  Activation of protein kinase C  Oxidative stress  Reduced serum levels of nerve growth factors
  • 8.
  • 10.
  • 12. classification  SYMMETRIC / ASYMMETRIC NEUROPATHY  AUTONOMIC NEUROPATHY  MONONEUROPATHY AND ENTRAPMENT SYNDROME  RADICULOPATHY/ POLYRADICULOPATHY  SUPER IMPOSED CIDP  TREATMENT INDUCED DIABETIC NEUROPATHY
  • 13.
  • 14.
  • 15. SYMMETRIC NEUROPATHY: SENSORY/SENSORIMOTOR/MOTOR DSPN – DISTAL SYMMETRIC POLYNEUROPATHY SMALL FIBER NEUROPATHY LARGE FIBER NEUROPATH Y MIXED SMALL AND LARGE FIBER NEUROPATHY MOST COMMON
  • 16. DSPN  Most common form of diabetic neuropathy  A mixed neuropathy with small, large fiber, autonomic, motor involvement( late stage).  In a patient with DM if there are clinical signs of autonomic abnormalities , DSPN is invariably present.  Insidious, progressive  DSPN as “the presence of symptoms and signs of peripheral nerve dysfunction in people with diabetes after exclusion of other causes”
  • 17.
  • 18. Symptoms:  As small fibers are predominantly involved early the symptoms are related to damage of small fibers.  Pain- dull constant pain/ sharp shooting or stabbing pain  Hyperalgesia  Allodynia  Loss of thermal sensation  Loss of pain(later stages) these symptoms are the main presentation in prediabetic individuals.
  • 19.  Symptoms worsens at night  Manifested in the feet more than the hands  Paresthesia or episodes of distorted sensation such as pins and needles,  tingling,  coldness,  numbness-feeling like walking in cotton,  burning sensation -hot foot.  often accompany the pain. as a whole these are called“POSITIVE SYMPTOMS” DSPN WITH LARGE FIBER NEUROPATHY – presents with insensate foot, Poor balancing, Distal weakness of toes& ankles in later stages are called ”NEAGATIVE SYMPTOMS”
  • 20. SIGNS: Sensory: loss or imapairment of sensation of toes and feet. Vibration sense often the first to go. as the sensory loss extends proximally from a sock to stocking distribution the finger tips become involved Autonomic: dry skin , fissures, callouses Motor: absent ankle reflex (large fibers), wasting of toe muscles
  • 22. CARDIAC AUTONOMIC NEUROPATHY SIGNS/SYMPTOMS MECHANISM RESTING TACHYCARDIA VAGAL IMPAIRMENT & (sympathetic takeover) REDUCED HRV EARLY FINDING REDUCED RESPONSE TO HR, BP IN EXERCISE, STRESS, SLEEP ORTHOSTATIC HYPOTENSION DAMAGE TO EFFERENT SYMPATHETIC VASOMOTOR FIBERS SYMPTOMS: Lightheadedness, dizziness, weakness, fatigue, neck pain, blurring of vision SILENT MI ALTERED PAIN THRESHOLD/ SUBTHRESHOLD ISCHEMIS NOT SUFFICIENT TO INDUCE PAIN, DYSFUNCTION OF AFFRENT AUTONOMIC FIBERS CARDIOMYOPATHY LEFT VENTRICLE DIASTOLIC DYSFUNCTION, LOW PEAK DIASTOLIC
  • 23. GI DIABETIC NEUROPATHY MECHANISM SIGNS/SYMPTOMS GASTROPARESIS DELAYED GASTRIC EMPTYING ( DUE TO HYPERGLYCEMIA OR HYPERGLYCEMIA INDUCED PARASYMPTHETIC DYSFUNCTION) BLOATING SENSATION EARLY SATIETY INDIGESTION NAUSEA, HEARTBURN ENTEROPATHY DIARRHEA ( NOCTURNAL DIARRHOEA) FECAL INCONTINENCE MAY ALTERNATE WITH CONSTIPATION COLONIC HYPOMOTILITY CONSTIPATION
  • 24. UROGENITAL D.NEUROPATHY BLADDER DYSFUNCTION (INABILITY TO SENSE FULL BLADDER, FAILURE TO VOID COMPLETELY) INCREASED FREQUENCY URGENCY, NOCTURIA, WEAK STREAM, DRIBBLING, INCONTINENCE, URINARY RETENTION MALE SEXUAL DYSFUNCTION ERECTILE DYSFUNCTION DECREASED LIBIDO PREMATURE EJACULATION, RETROGRADE EJACULATION FEMALE SEXUAL DYSFUNCTION DECREASED SEXUAL DESIRE, DYSPAREUNIA INADEQUATE LUBRICATION DECREASED SEXUAL AROUSAL SUDOMOTOR ANHIDROSIS GUSTATORY SWEATING
  • 25. OTHER AUTONOMIC NEUROPATHIC SYMPTOMS:  ABNORMAL PUPILLARY FUNCTION- SMALL UNREACTIVE PUPIL  HYPOGLYCMEIC UNAWARENESS  SLEEP APNEA
  • 26. MONO NEUROAPTHY  CRANIAL NERVE INVOLVEMENT:  Nerves of extra occular muscles are commonly affected.  Occulomotor nerve palsy III: ( 42% microvascular causes) # Abrupt onset, # retro orbital pain, # ptosis, # ophthalmoplegia with sparing of pupilary fuction Muscles supplied by 3rd nr: SR, IR, MR, IO Other cranial nerves affected: 6, 7, 4(less common)
  • 28. MONO NEUROAPTHY  Peripheral nerves – ulnar, median, radial, lateral popliteal nerve.  Entrappment neuropathies are common.  Carpel tunnel syndrome- median Nr  Pathogenesis: swelling of synovial sheaths around carpal tunnel due to fluid accumulation, inflammation, injury, external compression increases intra tunnel pressure which damages myelin sheath,impairs axonal flow & blocks micro circulation of median nerve causes pain , tingling, numbness sensation  Cubital tunnel syndrome- ulnar nerve at elbow  common peroneal Nr: at head of fibula
  • 29. Radiculopathy  TRUNCAL RADICULOPATHY: Abrupt onset of pain pain over area of chest and abdomen which worsens at night. thoracic lumbar spinal nerve roots are commonly involved focal anterior abdominal wall weakness- pseudohernia
  • 30. Lumbo sacral Radiculoplexopathy OTHER NAME: “BRUNS GARLAND SYNDROME” Diabetic amyotrophy, proximal motor neuropathy  Male>female in T2 DM  Pathogenesis : micro vasculitis leads to ischemeic nerve injury  Severe pain in unilateral/bilateral thighs, lowerback  Followed by lowerlimb muscle weakness often proximal & unilateral  Knee jerk reduced or absent
  • 31. SUPERIMPOSED CIDP  A chronic condition >8 weeks  A type of secondary CDIP  Chronic hyperglycemic state impairs neuronal microcirculation leads to myelin damage. As a chronic insult spinal nerve roots release chemokines into CSF leads to increse TNF, IL production activates CD4 cells which targets myelin sheaths and destroys leads to nerve damage.  Symptoms: presents with proximal muscle weakness and sensory involvement
  • 32. HYPOGLYCEMIC NEUROPATHY  It is treatment induced neuropathy where it probably due to microcirculation deficit in hyperglycemic period. As soon as the blood sugar levels was corrected microcirculation was not not restored as early because of endoneurial ischemia and the formation of axonal regeneration zonesupon attaining normoglycemic state producing ectopic depolarisations and pain starts 2-6 weeks after improvement of glycemic control
  • 33. INVESTIGATIONS  Blood glucose/ HbA1c  Urine analysis for protein/glucose  RFT/Electrolytes  Vitamin B12 levels  Serum protein  Lipid profile  CT/MRI brain (cranial nr palsy)  CT Pelvis (motor neuropathy)  NC study  EMG study
  • 34. Nerve conduction study  It is a measure of how fast the nerve conduct the impulses  Used in cases of paresthesia, weakness of arms or legs  Procedure:  1.electrodes will be taped to skin along the nerves that are being studied
  • 35. 2.Small stimulus is applied(electric current) that activate nerves 3.The electode will measure the current the current that travells down the nerve pathway If damaged? – the current will be slower/weaker Time of procedure- 30-90 min Complications- little discomfort from electric current, not painful Advantage: - non invasive, no anaesthesia needed - detect asymptomatic cases - monitering of progression/ remission of disease
  • 36.  INTERPRETATION:  Speed of conduction depends on diameter of nerve and degree of myelination.  In general , the range of normal conduction velocity will be approx 50-60 m/sec, however it vary from one nervr to another and and also individual variablility.  Eg: Slow NCS Indicates damage to myelin Slowing across wrist jt for motor &sensory latancies of median nerve Indiacates compression of median nr – carpal tunnel synd Slowing of all nr conduction in >1limb Indicates polyneuropathy
  • 38.
  • 39. CORRECTION OF UNDERLYING PATHOGENEIC MECHANISM:  NORMALISATION OF BLOOD GLUCOSE  ANTIOXIDANT THERAPHY  ALDOSE REDUCTASE INHIBITOR  GROWTH FACTOR ANALOGUE PHYSICAL APPROACH PHARMACOLOGICAL APPROACH PROPER FOOT WEAR NSAIDS FOOT CARE ANTI DEPRESSANTS PHYSIOTHERAPHY ANTICONVULSANTS NOCTURNAL SPLINT ANTIOXIDANTS, AGE INHIBITORS
  • 40. Anti convulsants:  GABA ANALOGUES: Gabapentin, pregabalin (-) Ady cyclase, +k+ channels, (-)ca2+influx
  • 41. pregabalin Gabapentin Initial dose 25-75mg 1-3*/day 100-300mg 1-3*/day Effective dose 300-600mg/day 900- 3,600mg/day Common Adverse effects Somnolence Dizziness Headache Ataxia Fatigue Weight gain xerostomia Somnolence Dizziness Headache Ataxia Fatigue Major adverse effects Hepatotoxic Angioedema Rhabdomyolysis Thrombocytopenia Suicidal thoughts Steven johnson syndrome Suicidal thoughts Seizure after discontinuation
  • 42. Anti depressants: SNRI duloxetine venlafaxine Initial dose 20-30 mg/ day 37.5 mg/day Maximum dose 60-120 mg/day 75-225 mg/day Common adverse effects Dizziness, insomnia, somnolence, anorexia, fatigue, decreased libido same Major adverse effects SJS, HT crisis, GI bleed, Delirium, MI, arrythmia, heapatotoxic, glaucoma, seizure, hyponatremia Neuroleptic malignant syndrome same
  • 43. Tricyclic anti-depressants Amitryptalline Nortyrptalline Desipramine Initial dose 10-25 mg/day Max dose 25-100 mg/day Adverse effects Dizziness, insomnia, somnolence, anorexia, fatigue, xerostommia, somnolence, urinary retention, , constipation, blurred vision, weight gain, mmydriasis Major adverse effects Same as duloxetine
  • 44. ALPHA LIPOIC ACID  Anti oxidant  600 mg/day iv for 5 -14 days  Improves neuropathic symptoms including pain
  • 45. Aldose reductase inhibitors  Tolrestat, epalrestat, ranirestat, fidarestat  Potentially slow or reverse the progression of neuropathy  Under clinical trail
  • 46. Refractory neuropathic pain  Phenothiazines  Opioids –Tramadol  Lidocaine  Mexiletine  Local nerve blocks